首页 | 本学科首页   官方微博 | 高级检索  
     


Treatment of Early (Limited)-Stage DLBCL
Affiliation:1. University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ, 85724–5025, USA;1. University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 429, Houston, TX 77030, USA;1. Memorial Sloan Kettering Cancer and Weill Cornell Medical College, New York, NY, USA;1. Division of Oncology, Washington University School of Medicine, St Louis, MO, USA;1. The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA;1. MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK;2. Department of Leukemia, Divison of Cancer Medicine, MD Anderson Cancer Centre University of Texas, Houston Texas, USA;1. The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Abstract:
Keywords:Limited stage  DLBCL  ibritumomab  tiuxetan  PET
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号